See also this year's filing and all EDGAR filings for this company.
PDF Report 0001364962_2014_Imperva_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001364962')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001364962')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001364962, Imperva INC
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesCurrent | 61,176,000 |
| 1 | LongTermDebt | 1,993,000 |
| 2 | remainder_Liabilities | 27,100,000 |
| 3 | IntangibleAssets | 0 |
| 4 | AssetsNoncurrent | 1,192,000 |
| 5 | AssetsCurrent | 164,390,000 |
| 6 | PropertyPlantAndEquipmentNet | 5,475,000 |
| 7 | remainder_Assets | 5,434,000 |
| 8 | SellingAndMarketingExpense | 81,500,000 |
| 9 | GeneralAndAdministrativeExpense | 24,436,000 |
| 10 | ResearchAndDevelopmentExpense | 27,556,000 |
| 11 | remainder_Expenses | 30,473,000 |
| 12 | remainder_Revenues | 137,759,000 |
| 13 | remainder_NetIncome | -125,000 |
| 14 | remainder_ComprehensiveNetIncome | -136,000 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 90,269,000 |
| 1 | Assets | 176,491,000 |
| 2 | Expenses | 163,965,000 |
| 3 | Revenues | 137,759,000 |
| 4 | StockholdersEquity | 86,222,000 |
| 5 | NetIncome | -26,331,000 |
| 6 | ComprehensiveNetIncome | -26,467,000 |
| 7 | BaseVar | 284,372,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.93 |
| 9 | EconomicCapitalRatio | 3.79 |